Menu Search
Equities

Genix Pharmaceuticals Corp

GENX:CVE

Genix Pharmaceuticals Corp

Actions
Consumer Staples Food Producers
  • Price (CAD)0.03
  • Today's Change0.00 / 0.00%
  • Shares traded4.00k
  • 1 Year change-40.00%
  • Beta-0.4604
Data delayed at least 15 minutes, as of Sep 16 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Genix Pharmaceuticals Corp's net income fell 309.27% from a loss of 1.07m to a larger loss of 4.40m despite revenues that grew -- from 0.00 to 12.35k.
Gross margin57.79%
Net profit margin-100,442.00%
Operating margin-97,277.39%
Return on assets-196.19%
Return on equity-661.13%
Return on investment-661.13%
More ▼

Cash flow in CADView more

In 2023, Genix Pharmaceuticals Corp increased its cash reserves by 25.46%, or 2.36k. Cash Flow from Financing totalled 223.04k or 1,805.99% of revenues. In addition the company used 220.67k for operations while cash from investing was breakeven.
Cash flow per share-0.0652
Price/Cash flow per share--
Book value per share-0.023
Tangible book value per share-0.0232
More ▼

Balance sheet in CADView more

Genix Pharmaceuticals Corp uses little or no debt in its capital structure.
Current ratio0.1413
Quick ratio0.0412
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.